Controlled Release Society’s Post

Softgel technology with lipid-based drug delivery systems, significantly boosts the bioavailability of new pharmaceutical molecules. Encapsulating active ingredients in a gelatin shell with lipid carriers improves solubility and absorption.

I am excited and thrilled to speak on this important topic comparing the various bioavailability enhancing technologies with case studies. Overlooking Softgel as a dosage form whether it is for DCS II or IV and considering it as a last resort instead of making it a first choice is proving costly both in terms of time and money especially with new treatment modalities like Protein degraders and other poorly bioavailable molecules. Please join us to see how we BUST various MYTHS with data/ facts on the MOST versatile dosage form ever, (that is Softgel)and see it for yourself to convince..

Join us at booth 514 at #IFPAC2024 happening right now! Our experts are ready to chat with you and answer all your questions. Come say hello and get to know more about us and our partners Phyllon GmbH and InSilicoTrials. #pharma #continuousmanufacturing #OCT #ParticleSimulation #ProcessControl

Medicine needs to be "delivered" to organs and cells to have effect - that is as true today as it will be tomorrow. This week Arex Advisor's Nelly Fransén participated in a meeting with the Sweden Drug Delivery Industry Group (SDDIG) in Uppsala. The meeting had a clear focus on collaborating around drug delivery expertise in Sweden - something that we at Arex support whole-heartedly.  Would you like to learn more on how we could support you with our drug development know-how? Let's connect! contactATarexadvisor.com.  #drugdelivery #formulation #cmc #pharma #regcmc #regulatoryaffairs

If you're attending the Expanded Access Programs World Congress next week in London, definitely find time to check out Ana Paula Tediosi's presentation, or catch her during the conference. Ana is a wealth of knowledge when it comes to end to end strategy for all types of access programs (among so many other things)! #earlyaccessprograms, #expandedaccess, #posttrialaccess, #compassionateuse, #clinicaltrials WEP Clinical

A great snapshot into last week's #MedComms Forum hosted by NetworkPharma Ltd and sponsored by aps Events & Media. It was wonderful to see so many faces (old and new). Here are some of my key personal highlights: Session 1 - Event Landscapes, Insights, and Demands 💻 Face-to-face engagement is important; however, virtual and hybrid meetings are often more inclusive for those unable to attend in-person. 🤝 Medical societies need to engage with new audiences and reformulate sponsorship policies to focus on partnerships. 🎯 The industry needs to focus on key impact indicators as well as key performance indicators to provide maximal benefit to society. Session 2 - Compliance, 2024 Code 📜 Navigating national codes can be challenging, with compliance barriers (and company risk tolerance) often hindering meaningful patient engagement. 🗞 The updated ABPI code of conduct is expected in the 4th quarter of 2024, with a 3-month transition period planned upon publication. Session 3 - Patient Inclusion 🎙 Meaningful patient engagement can be realised when patients are involved in the planning, delivery, evaluation, and leadership of scientific congresses. 🔗 Congress organisers should consider integrated patient tracks and accessibility when planning meetings to ensure maximal impact for everyone involved. 💼 Education, networking, and collaboration are key reasons why patients want to attend scientific congresses. #MedicalCommunications #MedicalAffairs #MedAffairs #Pharma #PatientEngagement #PatientInvolvement #PatientsInvolved #PatientAdvocacy #PatientsIncluded #IntegratedPatientEngagement

Listen in to this webinar where Tracy Nasarenko (GS1) and Joe Lipari (Systech) spoke about how standards play a crucial role in identifying products and their locations. Download now: https://bit.ly/3Sv15jB #Pharma #Traceability #GS1 #Systechone

Listen in to this webinar where Tracy Nasarenko (GS1) and Joe Lipari (Systech) spoke about how standards play a crucial role in identifying products and their locations. Download now: https://bit.ly/3Sv15jB #Pharma #Traceability #GS1 #Systechone

A real transformation in drug prices in US (#IRA) making healthcare more accessible, affordable and available. We are entering a new era of regulated drug pricing similar to EU and Asian countries. Pharma Cos must adapt their strategies to the new negotiating landscape. 💡 Dive into our study, which showcases the pivotal IRA provisions and the implications for pharmaceutical companies and patients: ➡ https://lnkd.in/d2wbv3bn #RolandBerger ✍  Filip Conic Matthias Bünte Atsushi Kiyoizumi Thilo Kaltenbach Michael Baur Prof. Dr. Torsten Henzelmann Julien Gautier Anne Moore, PhD Hans Nyctelius Koen Besteman Kai Balder Stephan Fath Marco Bühren Yoshihiro Suwa Aditya Agarwal Lennart Boesch Omer Saka Sara Barada Salil Churi

It was an interesting week at RDD, meeting the industry peers, partners and experts and discussing the latest developments in the pMDI space and its future path for various geographies #RDDUSA #RespiratoryDrugDelivery #Tucson #pMDI